this study is to analysis data generated from a previous study carried at another facility

To spread awareness and resources about Long COVID within Eastern North Carolina to healthcare providers, community health workers, lay health advisors, and community leaders. The assessments and evaluations are intended to gather prior knowledge and knowledge gained about Long COVID as well as facilitation and overall effectiveness of the educational sessions.

This is a short survey that will help NC CEAL prioritize resources, programming, and support to alleviate the impact of COVID-19 in communities across North Carolina.

Collecting nasal swab samples from symptomatic subjects potentially infected with COVID19 or influenza. These samples will be used to compare diagnostic testing accuracy of the new Panbio device panel versus other comparative devices.

The primary objective is to establish a comprehensive registry of hospitalized patients with respiratory failure. The registry will be a platform for forthcoming research initiatives. This registry's purpose is to collect vital participant data and specimens, capitalizing on the substantial expertise in respiratory and immunologic translational science at the University of North Carolina.

We are exploring the unique stressors that Black or African American women experienced due to the COVID-19 pandemic since "opening back up" -- returning to work, school, and in-person activities.

We will identify the relationship between pre-covid (March 2020) and current autoimmune disease testing volumes, positivity rates, and staff shortages. The statistical significance of the correlation coefficients (r value) will be assessed. T test mean correlation with be analyzed with the mean difference per test before and post covid-19. How laboratory management goals/priorities have changed will be summarized and analyzed for similarities, differences, and trends.

The purpose of this research study is to assess the successes and challenges that community pharmacies have faced in administering childhood vaccines to rural NC populations.

To evaluate the efficacy of bemnifosbuvir (BEM) compared with placebo in reducing all-cause hospitalization or all-cause death in COVID-19 outpatients receiving only supportive care.

This is a research study to find out if antiviral or other drugs can help people who have COVID symptoms that have lasted more than 3 months after a COVID infection. This condition is known as Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), including Long COVID.